share_log

Lake Street Initiates Coverage On Silk Road Medical With Buy Rating, Announces Price Target of $20

Lake Street Initiates Coverage On Silk Road Medical With Buy Rating, Announces Price Target of $20

Lake Street以买入评级启动对丝路医疗的报道,宣布目标股价为20美元
Benzinga ·  01/03 11:45

Lake Street analyst Frank Takkinen initiates coverage on Silk Road Medical (NASDAQ:SILK) with a Buy rating and announces Price Target of $20.

湖街分析师弗兰克·塔基宁以买入评级启动了对丝绸之路医疗(纳斯达克股票代码:SILK)的报道,并宣布目标股价为20美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发